Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2007

01-06-2007

Mental health service utilization among long-term cancer survivors

Authors: Craig C. Earle, Bridget A. Neville, Robert Fletcher

Published in: Journal of Cancer Survivorship | Issue 2/2007

Login to get access

Abstract

Background

Although generally well-adjusted, a subset of cancer survivors have been observed to experience ongoing psychological distress. There has been little study of mental health care utilization among cancer survivors, however.

Materials and methods

We identified a cohort of cancer survivors continuously enrolled in a managed care organization who were alive at least 5 years after a diagnosis of cancer and without evidence of recurrence. We matched them each to four controls without a history of cancer based on age, sex, and clinic location. We then obtained their health care claims and evaluated their health care utilization along with explanatory variables such as cancer type, non-cancer comorbid conditions, and types of health care providers seen.

Results

One thousand one hundred eleven survivors were matched to 4,444 controls. Cancer survivors were more likely than controls to have a mental health diagnosis (33.5 vs. 30.3%, p < 0.05), accounted for mostly by anxiety and sleep disorders. Other predictors of receiving any mental health diagnosis on multivariable analysis were age: Odds Ratio (OR) 0.99 (95% Confidence Interval (CI) 0.99–0.99) for each year; male sex: OR 0.87 (95% CI 0.77–0.99), and comorbidity: OR 0.56 (95% CI 0.49–0.64) for each point on the Charlson scale. The largest subgroup was breast cancer survivors, who were more likely to have a diagnosis of major affective disorder than were female survivors of other cancers. Survivors had more outpatient medical visits in general (mean 27.4 versus 21.9, p < 0.001) and specifically more mental health visits (2.5 versus 1.7 on average, p < 0.001) than did controls.

Conclusion

Long-term cancer survivors have increased rates of mental health care utilization. Given the size and growth of the survivor population, this represents a significant amount of ongoing distress with important health resource allocation implications for policy makers.
Literature
1.
go back to reference Burgess, C., Cornelius, V., & Love, S. (2005). Depression and anxiety in women with early breast cancer: Five year observational cohort study. BMJ, 330, 702.PubMedCrossRef Burgess, C., Cornelius, V., & Love, S. (2005). Depression and anxiety in women with early breast cancer: Five year observational cohort study. BMJ, 330, 702.PubMedCrossRef
2.
go back to reference Carney, C. P., Woolson, R. F., & Jones, L. (2004). Occurrence of cancer among people with mental health claims in an insured population. Psychosomatic Medicine, 66, 735–743.PubMedCrossRef Carney, C. P., Woolson, R. F., & Jones, L. (2004). Occurrence of cancer among people with mental health claims in an insured population. Psychosomatic Medicine, 66, 735–743.PubMedCrossRef
3.
go back to reference Charlson, M. E., Sax, F. L., & MacKenzie, C. R. (1986). Morbidity during hospitalization: Can we predict it? Journal of Chronic Diseases, 40, 705–712.CrossRef Charlson, M. E., Sax, F. L., & MacKenzie, C. R. (1986). Morbidity during hospitalization: Can we predict it? Journal of Chronic Diseases, 40, 705–712.CrossRef
4.
go back to reference Charlson, M. E., Pompei, P., & Ales, K. L. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373–383.PubMedCrossRef Charlson, M. E., Pompei, P., & Ales, K. L. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373–383.PubMedCrossRef
5.
go back to reference Deyo, R. A., Cherkin, D. C., & Ciol, M. A. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45, 613–619.PubMedCrossRef Deyo, R. A., Cherkin, D. C., & Ciol, M. A. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45, 613–619.PubMedCrossRef
6.
go back to reference Field, T. S., Cernieux, J., & Buist, D. (2004). Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research Network. Journal of the National Cancer Institute, 96, 148–152.PubMedCrossRef Field, T. S., Cernieux, J., & Buist, D. (2004). Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research Network. Journal of the National Cancer Institute, 96, 148–152.PubMedCrossRef
7.
go back to reference Hewitt, M., Breen, N., & Devesa, S. (1999). Cancer prevalence and survivorship issues: Analyses of the 1992 National Health Interview Survey. Journal of the National Cancer Institute, 91, 1480–1486.PubMedCrossRef Hewitt, M., Breen, N., & Devesa, S. (1999). Cancer prevalence and survivorship issues: Analyses of the 1992 National Health Interview Survey. Journal of the National Cancer Institute, 91, 1480–1486.PubMedCrossRef
8.
go back to reference Hewitt, M., & Rowland, J. H. (2002). Mental health service use among adult cancer survivors: Analyses of the National Health Interview Survey. Journal Clinical Oncology, 20, 4581–4590.CrossRef Hewitt, M., & Rowland, J. H. (2002). Mental health service use among adult cancer survivors: Analyses of the National Health Interview Survey. Journal Clinical Oncology, 20, 4581–4590.CrossRef
9.
go back to reference Honda, K., & Goodwin, R. D. (2004). Cancer and mental disorders in a national community sample: Findings from the National Comorbidity Survey. Psychotherapy and Psychosomatics, 73, 235–242.PubMedCrossRef Honda, K., & Goodwin, R. D. (2004). Cancer and mental disorders in a national community sample: Findings from the National Comorbidity Survey. Psychotherapy and Psychosomatics, 73, 235–242.PubMedCrossRef
10.
go back to reference (2005). Institute of Medicine: From cancer patient to cancer survivor: Lost in transition. Washington: National Academies. (2005). Institute of Medicine: From cancer patient to cancer survivor: Lost in transition. Washington: National Academies.
11.
go back to reference Keating, N. L., Norredam, M., & Landrum, M. B. (2005). Physical and mental health status of older long-term cancer survivors. Journal of the American Geriatrics Society, 53, 2145–2152.PubMedCrossRef Keating, N. L., Norredam, M., & Landrum, M. B. (2005). Physical and mental health status of older long-term cancer survivors. Journal of the American Geriatrics Society, 53, 2145–2152.PubMedCrossRef
12.
go back to reference Klabunde, C. N. (2000). Development of a comorbidity index using physician claims data. Journal of Clinical Epidemiology, 53, 1258–1267.PubMedCrossRef Klabunde, C. N. (2000). Development of a comorbidity index using physician claims data. Journal of Clinical Epidemiology, 53, 1258–1267.PubMedCrossRef
13.
go back to reference Kornblith, A. B., & Ligibel, J. (2003). Psychosocial and sexual functioning of survivors of breast cancer. Seminars in Oncology, 30, 799–813.PubMedCrossRef Kornblith, A. B., & Ligibel, J. (2003). Psychosocial and sexual functioning of survivors of breast cancer. Seminars in Oncology, 30, 799–813.PubMedCrossRef
14.
go back to reference Kosten, T. R., Bryant, K., & Rounsaville, B. J. (1990). The SCID: A clinical instrument for assessing psychiatric disorders. NIDA Research Monograph, 105, 213–219.PubMed Kosten, T. R., Bryant, K., & Rounsaville, B. J. (1990). The SCID: A clinical instrument for assessing psychiatric disorders. NIDA Research Monograph, 105, 213–219.PubMed
15.
go back to reference Massie, M. J. (2004). Prevalence of depression in patients with cancer. Journal of the National Cancer Institute Monographs, 57–71. Massie, M. J. (2004). Prevalence of depression in patients with cancer. Journal of the National Cancer Institute Monographs, 57–71.
16.
go back to reference Nekhlyudov, L., Li, R., & Fletcher, S. W. (2005). Information and involvement preferences of women in their 40s before their first screening mammogram. Archives of Internal Medicine, 165, 1370–1374.PubMedCrossRef Nekhlyudov, L., Li, R., & Fletcher, S. W. (2005). Information and involvement preferences of women in their 40s before their first screening mammogram. Archives of Internal Medicine, 165, 1370–1374.PubMedCrossRef
17.
go back to reference Polsky, D., Doshi, J. A., & Marcus, S. (2005). Long-term risk for depressive symptoms after a medical diagnosis. Archives of Internal Medicine, 165, 1260–1266.PubMedCrossRef Polsky, D., Doshi, J. A., & Marcus, S. (2005). Long-term risk for depressive symptoms after a medical diagnosis. Archives of Internal Medicine, 165, 1260–1266.PubMedCrossRef
18.
go back to reference Ross, L., Johansen, C., & Dalton, S. O. (2003). Psychiatric hospitalizations among survivors of cancer in childhood or adolescence. New England Journal of Medicine, 349, 650–657.PubMedCrossRef Ross, L., Johansen, C., & Dalton, S. O. (2003). Psychiatric hospitalizations among survivors of cancer in childhood or adolescence. New England Journal of Medicine, 349, 650–657.PubMedCrossRef
19.
go back to reference Wagner, E. H., Greene, S. M., & Hart, G. (2005). Building a research consortium of large health systems: the Cancer Research Network. Journal of the National Cancer Institute. Monographs, 3–11. Wagner, E. H., Greene, S. M., & Hart, G. (2005). Building a research consortium of large health systems: the Cancer Research Network. Journal of the National Cancer Institute. Monographs, 3–11.
Metadata
Title
Mental health service utilization among long-term cancer survivors
Authors
Craig C. Earle
Bridget A. Neville
Robert Fletcher
Publication date
01-06-2007
Published in
Journal of Cancer Survivorship / Issue 2/2007
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-007-0013-2

Other articles of this Issue 2/2007

Journal of Cancer Survivorship 2/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine